创伤性脑损伤和辅酶Q10:一个概述
David Mantle1, Mollie Dewsbury2, Alexander David Mendelow3
1Pharma Nord (UK) Ltd., Morpeth NE61 2DB, UK.
International journal of molecular sciences
|June 13, 2025
概括
补充辅酶Q10 (CoQ10) 可能为创伤性脑损伤 (TBI) 提供新的治疗策略. 这种抗氧化和抗炎剂在动物模型中表现有希望,并可能通过保护大脑和心脏来改善TBI患者的结果.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 创伤性脑损伤 (TBI) 会导致严重的发病率和死亡率.
- 缺血症,线粒体功能障碍,氧化应激和炎症是TBI诱导的大脑损伤的关键因素.
- 目前对TBI的治疗策略是不够的,需要新的方法.
研究的目的:
- 在TBI的动物模型中审查补充辅酶Q10 (CoQ10) 的疗效.
- 探索辅酶Q10在治疗TBI患者中的潜在应用.
- 讨论克服血脑屏障限制的策略,以 CoQ10 输送.
主要方法:
- 在TBI动物模型中对CoQ10的现有文献的审查.
- 分析了CoQ10作为抗氧化剂和抗炎剂的生物化学特性.
- 讨论鼻内输送作为一种提高大脑CoQ10水平的方法.
主要成果:
- 在临床前的TBI模型中,CoQ10显示出潜在的治疗益处.
- 鼻内注射可能会促进CoQ10直接进入大脑.
- 强调了CoQ10在缓解心脏功能障碍和TBI患者免疫失调方面的作用.
结论:
- 补充辅酶Q10为TBI管理提供了一个有前途的治疗途径.
- 用CoQ10准线粒体功能障碍和氧化应激可以减少大脑损伤.
- CoQ10还可以预防TBI患者的心血管并发症,改善整体结果.
相关概念视频
Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Coagulation
5.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.7K


